(Q27851555)

13 November 2016

title

Gene amplification CCNE1 is related to poor survival and potential therapeutic target in ovarian cancer (English)

1 reference

PubMed

PubMed publication ID

13 November 2016

1 reference

Naomi Nakayama

1

0 references

Kentaro Nakayama

2

0 references

Yeasmin Shamima

3

0 references

Masako Ishikawa

4

0 references

Atsuko Katagiri

5

0 references

Kouji Iida

6

0 references

Khoji Miyazaki

Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis

7

0 references

language of work or name

English

0 references

publication date

1 June 2010

0 references

language of work

Cancer

0 references

volume

116

0 references

issue

11

0 references

page(s)

2621-34

0 references

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24987

Human cyclin E, a nuclear protein essential for the G1-to-S phase transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24987

Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24987

Loss of cell cycle regulators p27(Kip1) and cyclin E in transitional cell carcinoma of the bladder correlates with tumor grade and patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24987

21 January 2018

Cancer statistics, 1995.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24987

7 January 2021

Amplification of a chromatin remodeling gene, Rsf-1/HBXAP, in ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24987

7 January 2021

Notch3 gene amplification in ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24987

7 January 2021

Sequence mutations and amplification of PIK3CA and AKT2 genes in purified ovarian serous neoplasms

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24987

7 January 2021

Amplicon profiles in ovarian serous carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24987

7 January 2021

Expression and prognostic value of the cell-cycle regulatory proteins, Rb, p16MTS1, p21WAF1, p27KIP1, cyclin E, and cyclin D2, in ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24987

7 January 2021

Cyclin E expression is correlated with tumor progression and predicts a poor prognosis in patients with ovarian carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24987

7 January 2021

Deregulation of cyclin E in human cells interferes with prereplication complex assembly

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24987

7 January 2021

Induction of centrosome amplification and chromosome instability in human bladder cancer cells by p53 mutation and cyclin E overexpression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24987

7 January 2021

Cyclin E and survival in patients with breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24987

7 January 2021

Expression of cyclin E and cyclin-dependent kinase 2 correlates with metastasis and prognosis in colorectal carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24987

7 January 2021

Cyclin E and p16 immunoreactivity in epithelioid trophoblastic tumor--an aid in differential diagnosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24987

7 January 2021

Modulation of cisplatin sensitivity by taxol in cisplatin-sensitive and -resistant human ovarian carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24987

7 January 2021

Molecular pathogenesis of ovarian borderline tumors: new insights and old challenges

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24987

7 January 2021

Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24987

7 January 2021

Tissue array analysis of expression microarray candidates identifies markers associated with tumor grade and outcome in serous epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24987

7 January 2021

Cyclin E overexpression and amplification in human tumours

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24987

7 January 2021

Cyclin E in normal and neoplastic cell cycles

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24987

7 January 2021

Kinase-independent function of cyclin E

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24987

7 January 2021

Analysis of gene amplification and prognostic markers in ovarian cancer using comparative genomic hybridization for microarrays and immunohistochemical analysis for tissue microarrays

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24987

7 January 2021

Integrated genome-wide DNA copy number and expression analysis identifies distinct mechanisms of primary chemoresistance in ovarian carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24987

7 January 2021

Cyclin E at the centre of an identity crisis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24987

7 January 2021

Drosophila neuroblast asymmetric divisions: cell cycle regulators, asymmetric protein localization, and tumorigenesis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24987

7 January 2021

https://api.crossref.org/works/10.1002%2FCNCR.24987

1 reference

7 January 2021

Phase II study of E7070 in patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24987

7 January 2021

A randomized phase II pharmacokinetic and pharmacodynamic study of indisulam as second-line therapy in patients with advanced non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24987

7 January 2021

Cyclin E amplification and overexpression in clear cell adenocarcinoma of the ovary

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24987

7 January 2021